首页> 中文期刊> 《医药与保健》 >50例苯巴比妥钠联合安定治疗小儿惊厥的临床有效性观察

50例苯巴比妥钠联合安定治疗小儿惊厥的临床有效性观察

         

摘要

目的:对小儿惊厥治疗中开展苯巴比妥钠以及安定联合治疗方案的可行性进行分析。方法随机选择本儿童医院2014年01月-2016年01月接收的50例小儿惊厥患者,分成2个组,其中治疗组有25例患儿,均接受苯巴比妥钠以及安定联合方案治疗;对照组有25例患儿,均接受安定方案治疗,观察所有入选对象疗效。结果结束治疗程序后,治疗组有效率96.00%,对照组72.00%。此外,用药一个月后,治疗组有3例患儿复发,同时对照组有10例患儿复发,2组疗效及预后对照均有差距(P<0.05)。结论在小儿惊厥患者治疗中,推行苯巴比妥钠以及安定联合治疗方案具有可行性,可进一步提升患儿疗效,避免复发现象发生,值得推广。%Objective For the treatment of infantile convulsions of phenobarbital sodium and stability analysis for feasibility of combination therapy. Methods Randomly choose the children's hospital in January 2014-01, 2016 received 50 patients with infantile convulsion, divided into two groups, the treatment group with 25 cases, all accept phenobarbital sodium and stable joint solution treatment;Control group with 25 cases of stable solution treatment, observation curative effect all selected objects. Results After treatment, the treatment group effective rate was 96.00%, and 72.00%in control group. In addition, a month later, the drug treatment group 3 cases relapse, and the control group with 10 cases relapse, curative effect and prognosis of two groups compare have difference (P<0.05). Conclusion In treatment of patients with infantile convulsion, phenobarbital sodium and stable combined treatment scheme is feasible, and can further enhance children curative effect, avoid recurrence phenomenon, is worth promoting.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号